NCT03296982View on ClinicalTrials.gov

Variability of Whole Blood Clotting Time Measurements in Ex Vivo Human Blood Samples Spiked With Anticoagulants

CompletedOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Healthy
Interventions
OTHER

Blood drawn by direct venipuncture

Subjects will have blood sampled (12 mL/sample) a total of 8 times by direct venipuncture. Samples will be spiked with predetermined concentrations of anticoagulants, or saline sham.

DRUG

edoxaban

DRUG

Enoxaparin

DRUG

Saline sham

All Listed Sponsors
collaborator

Quintiles, Inc.

INDUSTRY

lead

Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc.

INDUSTRY

NCT03296982 - Variability of Whole Blood Clotting Time Measurements in Ex Vivo Human Blood Samples Spiked With Anticoagulants | Biotech Hunter | Biotech Hunter